- Tags: presbyopia
Products
FDA approves J&J's TECNIS PureSee IOL for cataract patients
Approval is the first extended-depth-of-focus lens with no warning on loss of contrast sensitivity; availability to follow later this year.
Pipeline
TECLens study treats first patient for noninvasive refractive vision correction
First-in-human trial is evaluating the in-office qCXL technology as an alternative to traditional refractive surgical procedures for strengthening corneal integrity.
Pipeline
FDA accepts sNDA of phentolamine 0.75% for presbyopia
Already FDA-approved and commercially available as RYZUMVI, the eye drop has been assigned a PDUFA date of Oct. 17, 2026.
Products
Alcon launches TOTAL30 Multifocal for Astigmatism toric contact lens
Designed for astigmatic presbyopes, the latest TOTAL30 is the only monthly MF toric lens featuring proprietary Water Gradient Technology.
Pipeline
FDA clears Cloudbreak Pharma's IND for phase 2 presbyopia drop trials
Clearance green lights advancement of CBT-199, an ophthalmic emulsion with a proprietary, water-free formulation and parasympathomimetic miotic agent.
Products
FDA approves Tenpoint's YUVEZZI as first dual-agent presbyopia drop
First and only combination drop of carbachol and brimonidine tartrate achieves miosis within 30 minutes and lasts up to 10 hours following once-daily dosing.
Research
New QLOSI safety data supports drop as pupil selective for presbyopia
Head-to-head trial finds pilocarpine 0.4% resulted in no significant changes in ciliary muscle or lens thickness following dosing.
Pipeline
FDA approves Allotex's IDE for US study of tissue-based solution for presbyopia
Company gets all-clear for clinical trial on its tissue addition technology and customized, laser-shaped human corneal tissue to restore vision.
Products
FDA clears first EDOF contact lens for presbyopia
U.S. approval is first for a daily disposable, extended-depth-of-field lens requiring no patient cognitive adaptation period for presbyopia correction.
Business
TearOptix secures funding for presbyopia MF lens tech
Company is developing a tear-and-blink-responsive contact lens technology utilizing tear film dynamics to work with the eye’s natural physiology.
Products
VIZZ presbyopia eye drops launch in the US
Commercial rollout of first-ever aceclidine-based eye drop for presbyopia expected to begin this month, with broader availability later in Q4 2025.Products
FDA approves LENZ Therapeutics' VIZZ for presbyopia
LNZ100, now VIZZ, is the first and only FDA-approved aceclidine-based eye drop for the treatment of presbyopia in adults.
Business
Topcon invests in OKKO Health's home vision monitoring platform
The OKKO Health app is available on patients’ digital devices to enable ongoing self-monitoring of macular degeneration.
Pipeline
LENZ and Théa partner on Canadian commercialization of presbyopia eye drop
Licensing and commercialization agreement gives LENZ $70 million in upfront and milestone payments; news comes as company awaits FDA approval.
Pipeline
Opus Genetics' VEGA-3 presbyopia trial meets endpoints for phentolamine 0.75%
Topline data found a statistically significant number of patients achieved a ≥15-letter improvement in binocular DCNVA; H2 2025 NDA submission expected.
Products
J&J launches Acuvue Oasys Max 1-Day MF contact lens for astigmatism
Newest addition to the ACUVUE brand is the first and only disposable contact lens for patients with both astigmatism and presbyopia.
Research
Investigators identify new OCT-based biomarker for presbyopic accommodation
Crystalline lens thickness may be a sensitive indicator for presbyopic accommodation.
Pipeline
FDA accepts Tenpoint's Brimochol PF NDA for presbyopia
Fixed-dose-combo eye drop of brimonidine tartrate and carbachol has demonstrated a statistically significant reduction in pupil size up to 10 hours; PDUFA date set for January.
Pipeline
FDA OKs clinical trial on Atia Vision's novel IOL for cataract patients
IDE approval brings company one step closer toward seeking regulatory clearance for the OmniVu Lens System, a dual-optic IOL.
Business